Induction chemotherapy followed by chemoradiation versus upfront chemoradiation in locally advanced head and neck cancers A prospective randomized study

Induction Chemotherapy Versus Upfront Chemoradiation for Locoregionally Advanced of Head and Neck Cancer

Accelerated Fractionation Radiotherapy and Chemotherapy Might Improve Loco-Regional Control of Head and Neck Squamous Cell Carcinoma

CONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN

Evaluation of Adaptive Radiation Therapy in Treatment of Locally Advanced Head and Neck cancers

Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation alone For Locally Advanced Laryngeal & Nasopharyngeal Cancers: A Retrospective Study

Weekly cisplatin (40 mg/m2) versus three-weekly (100mg/m2) cisplatin delivered concurrently with radiotherapy in high risk head and neck cancer patients

Optimizing a Convenient Protocol in Induction Treatment Of Locally Advanced Head And Neck Cancers: Taxotere- Cisplatin- 5 Fluorouracil versus Cisplatin-5 Fluorouracil

EVALUATION OF THE EFFICACY AND TOXICITY OF NEO-ADJUVANT SHORT COURSE RADIATION THERAPY CONCURRENTLY WITH CONTINUOUS INFUSION 5-FLUOROURACIL IN THE MANAGEMENT OF LOCALLY ADVANCED

Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience